Author:
Moore David,Connock Martin J,Wraith Ed,Lavery Christine
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference20 articles.
1. Neufeld EF, Muenzer J: The mucopolysaccharidoses. The metabolic and molecular bases of inherited disease. Edited by: Scriver CR, Sly WS. 2000, New York: McGraw-Hill, 3421-3452.
2. Wraith JE, Beck M, Lane R, van der PA, Shapiro E, Xue Y: Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics. 2007, 120: e37-e46. 10.1542/peds.2006-2156.
3. Connock M, Burls AB, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C: The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease. Health Technol Assess. 2006, 10 (24):
4. Burls A, Austin D, Moore D: Commissioning for rare diseases: view from the frontline. BMJ. 2005, 331: 1019-1021. 10.1136/bmj.331.7523.1019.
5. McCabe C, Claxton K, Tsuchiya A: Orphan drugs and the NHS: should we value rarity?. BMJ. 2005, 331: 1016-1019. 10.1136/bmj.331.7523.1016.
Cited by
123 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献